Metformin prescription for insured adults with prediabetes from 2010 to 2012: A retrospective cohort study

Annals of Internal Medicine

Volumn 162, Issue 8, 2015, Pages 542-548

  Moin, Tannaz ^a   Li, Jinnan ^a   Duru, O Kenrik ^a   Ettner, Susan ^a   Turk, Norman ^a   Keckhafer, Abigail ^b   Ho, Sam ^c   Mangione, Carol M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNITEDHEALTH GROUP   (United States)

^c UnitedHealthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; ANTIDIABETIC AGENT;

ADULT; ADULT DISEASE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYER; FEMALE; HEALTH CARE PLANNING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RETROSPECTIVE STUDY; TREATMENT INDICATION; COMPLICATION; DIABETES MELLITUS; HEALTH INSURANCE; LIFESTYLE; OBESITY; PREDIABETIC STATE; SEX DIFFERENCE; UNITED STATES; YOUNG ADULT;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSURANCE, HEALTH; LIFE STYLE; MALE; METFORMIN; MIDDLE AGED; OBESITY; PREDIABETIC STATE; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84928157134     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-1773     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Accessed at www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf on 19 February 2015.
2. Centers for Disease Control and Prevention. Prediabetes: Could It Be You? Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/diabetes/pubs/statsreport14/prediabetes-infographic.pdf on 4 February 2015.
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. [PMID: 11832527]
4. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al; Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230-6. [PMID: 14633807]
5. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-9. [PMID: 17098085]
6. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289-97. [PMID: 16391903]
7. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-9. [PMID: 18502303] doi:10.1016/S0140-6736 (08) 60766-7
8. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-86. [PMID: 19878986] doi:10.1016/S0140-6736 (09) 61457-4
9. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31:67-75. [PMID: 22232096] doi:10.1377/hlthaff.2011.1009
10. Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and metaanalysis. BMC Public Health. 2010;10:653. [PMID: 21029469] doi: 10.1186/1471-2458-10-653
11. Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37:922-33. [PMID: 24652723] doi:10.2337/dc13-2195
12. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014;37:943-9. [PMID: 24652724] doi:10.2337/dc13-1954
13. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37 Suppl 1:S14-80. [PMID: 24357209] doi:10.2337/dc14-S014
14. Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35:731-7. [PMID: 22442396] doi:10.2337/dc11-1299
15. Schmittdiel JA, Adams SR, Segal J, Griffin MR, Roumie CL, Ohnsorg K, et al. Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care. 2014;37:565-8. [PMID: 24271190] doi:10.2337/dc13-1223
16. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31 Suppl 1:S12-54. [PMID: 18165335] doi:10.2337/dc08-S012
17. Heilbrunn E. Top Health Insurance Companies. New York: U. S. News & World Report; 2013. Accessed at http://health.usnews.com/health-news/health-insurance/articles/2013/12/16/top-health-insurance-companies on 28 December 2013.
18. Duru OK, Mangione CM, Chan C, Keckhafer A, Kimbro L, Kirvan KA, et al. Evaluation of the Diabetes Health Plan to improve diabetes care and prevention. Prev Chronic Dis. 2013;10:E16. [PMID: 23369769] doi:10.5888/pcd10.120150
19. Xiao J, Chen S, Zhang C, Chang S. The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol Endocrinol. 2012;28:956-60. [PMID: 22808990] doi:10.3109/09513590.2012.705368
20. Baran S, Api M, Goksedef BP, Cetin A. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome. Arch Gynecol Obstet. 2010;282:439-43. [PMID: 20473763] doi:10.1007/s00404-010-1497-y
21. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol. 2008;199:596-609. [PMID: 19084097] doi:10.1016/j.ajog.2008.09.010
22. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377-99. [PMID: 21225900] doi:10.1002/sim.4067
23. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91:473-89. doi: 10.1080/01621459.1996.10476908
24. Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, et al; Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006;61:1075-81. [PMID: 17077202]
25. Diabetes Prevention Program Research Group. The 10-year costeffectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35:723-30. [PMID: 22442395] doi:10.2337/dc11-1468
26. Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Costeffectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care. 2007;30:2548-52. [PMID: 17670917]
27. Fradkin JE, Roberts BT, Rodgers GP. What's preventing us from preventing type 2 diabetes? N Engl J Med. 2012;367:1177-9. [PMID: 23013070]
28. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care. 2007;30:228-33. [PMID: 17259486]
29. Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation? N Engl J Med. 2003;349:868-74. [PMID: 12944573]
30. Nathan DM, Davidson MB, De Fronzo RA, Heine RJ, Henry RR, Pratley R, et al; American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30:753-9. [PMID: 17327355]